Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/27/17 → 09/27/20 |
Funding
- Genentech Incorporated: $14,485.00
A Phase 1b, Randomized, blinded, placebo controlled, multiple ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of subcutaneous BFKB8488A in patients with type 2 Diabetes Mellitus
- Dandona, Paresh (PI)
- Batra, Manav (CoI)
- Ghanim, Husam (CoI)
- Makdissi, Antoine (CoI)
Project: Research